Membrane encapsulated nanoparticles and method of use
US12097290B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Mar 14, 2013 |
| Grant date | Sep 24, 2024 |
| Priority date | — |
| Expiry date | Mar 14, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/80
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are nanoparticles and methods of using and making thereof. The inventive nanoparticle comprises a) an inner core comprising a non-cellular material; and b) an outer surface comprising a cellular membrane derived from a cell or a membrane derived from a virus. Medicament delivery systems or pharmaceutical compositions comprising the inventive nanoparticles are also provided. Further provided are immunogenic compositions comprising the inventive nanoparticles, and methods of using the inventive immunogenic compositions for eliciting an immune response, and for treating or preventing diseases or condition, such as neoplasm or cancer, or disease or conditions associated with cell membrane inserting toxin. Vaccines comprising the immunogenic composition comprising the nanoparticles are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.